Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q1 2026: Pfizer 14.451, Moderna 0.145.
Pfizer vs Moderna Net Worth and Market Cap
Pfizer (PFE) and Moderna (MRNA) are peers in Vaccines. Pfizer reported revenue of $14.5B as of Q1 2026, compared with $145M for Moderna. Pfizer leads on revenue.
Pfizer's gross margin is 67.3% versus 35.9% for Moderna. Pfizer's net margin is 18.6% versus -539.3% for Moderna.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Pfizer, Moderna.| Metric | Pfizer | Moderna |
|---|---|---|
| Market Cap | - | - |
| Revenue | $14.45B | $145.00M |
| Cost of Revenue | $4.73B | $93.00M |
| Gross Profit | $9.72B | $52.00M |
| Operating Income | $4.03B | $-815.00M |
| Net Income | $2.69B | $-782.00M |
| R&D Expense | $2.63B | $651.00M |
| Earnings Per Share | $0.47 | -$1.96 |
| Gross Margin | 67.3% | 35.9% |
| Operating Margin | 27.9% | -562.1% |
| Net Profit Margin | 18.6% | -539.3% |
| Free Cash Flow | $2.18B | $-563.00M |
| Cumulative Free Cash Flow | $356.40B | $7.37B |
| Operating Cash Flow | $2.62B | $-526.00M |
| Cash & Equivalents | $1.70B | $1.72B |
Prefer Sterling in Google
Add sterlingcharts.com as a preferred source so our charts can appear with a preferred badge in Google Top Stories, AI Mode, and AI Overviews.